California Public Employees Retirement System Sells 11,108 Shares of agilon health, inc. (NYSE:AGL)

California Public Employees Retirement System decreased its position in shares of agilon health, inc. (NYSE:AGLFree Report) by 2.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 402,879 shares of the company’s stock after selling 11,108 shares during the period. California Public Employees Retirement System’s holdings in agilon health were worth $5,056,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of the company. Morgan Stanley boosted its stake in shares of agilon health by 8.9% during the 3rd quarter. Morgan Stanley now owns 44,819,378 shares of the company’s stock worth $795,992,000 after purchasing an additional 3,674,311 shares during the period. Wellington Management Group LLP grew its stake in shares of agilon health by 8.3% during the third quarter. Wellington Management Group LLP now owns 41,318,777 shares of the company’s stock valued at $733,821,000 after buying an additional 3,162,094 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of agilon health by 0.4% in the third quarter. Vanguard Group Inc. now owns 28,355,275 shares of the company’s stock worth $503,590,000 after buying an additional 111,487 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of agilon health by 4.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,796,884 shares of the company’s stock worth $31,913,000 after buying an additional 70,443 shares during the period. Finally, TD Asset Management Inc lifted its stake in shares of agilon health by 31.3% during the 3rd quarter. TD Asset Management Inc now owns 1,520,066 shares of the company’s stock worth $26,996,000 after acquiring an additional 362,565 shares during the last quarter.

agilon health Price Performance

AGL opened at $4.83 on Friday. The firm has a market capitalization of $1.99 billion, a PE ratio of -7.43 and a beta of 0.52. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.51 and a quick ratio of 1.51. The business’s 50-day moving average is $5.41 and its two-hundred day moving average is $9.04. agilon health, inc. has a 1 year low of $4.41 and a 1 year high of $26.75.

agilon health (NYSE:AGLGet Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.13). agilon health had a negative return on equity of 21.74% and a negative net margin of 5.76%. The firm had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the previous year, the firm earned ($0.14) EPS. The firm’s quarterly revenue was up 71.8% on a year-over-year basis. Research analysts anticipate that agilon health, inc. will post -0.33 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have weighed in on the company. SVB Leerink lowered agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, January 8th. Jefferies Financial Group reiterated a “hold” rating and set a $6.50 price objective (down previously from $25.00) on shares of agilon health in a report on Monday, February 26th. Stifel Nicolaus dropped their target price on shares of agilon health from $8.00 to $7.00 and set a “hold” rating on the stock in a research note on Wednesday. Royal Bank of Canada decreased their price target on shares of agilon health from $11.00 to $8.00 and set an “outperform” rating for the company in a research note on Wednesday, February 28th. Finally, Leerink Partnrs lowered agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, January 8th. One investment analyst has rated the stock with a sell rating, twelve have given a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $9.32.

Check Out Our Latest Report on agilon health

agilon health Company Profile

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

See Also

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGLFree Report).

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.